-- 美國央行週三發布的最新褐皮書顯示,儘管中東戰事持續,但大多數聯邦儲備區自3月初以來經濟活動均有所增長。 這份由紐約聯邦儲備銀行根據截至4月6日收集的數據編制的最新報告指出,八個聯邦儲備區的經濟活動出現小幅至中度增長,而其餘四個地區的經濟活動幾乎沒有變化或出現下滑。 先前於3月4日發布的褐皮書顯示,大多數聯邦儲備區自1月中旬以來經濟均有所增長,整體經濟前景「樂觀」。報告的數據收集於2月底美以與伊朗爆發戰爭前。 最新報告週三指出,“中東衝突被認為是造成不確定性的主要來源,使企業在招聘、定價和資本投資方面的決策變得複雜,許多企業採取了觀望態度。” 有報導稱,在美伊兩週停火協議到期前,華盛頓和德黑蘭可能會重返巴基斯坦舉行第二輪會談。在伊斯蘭堡舉行的首輪和平談判無果。 聯準會表示,儘管部分地區遭遇嚴寒冬季,燃油價格上漲,但消費者支出仍小幅成長。 「許多地區持續出現消費者財務緊張、價格敏感度上升以及食品銀行和其他社會服務機構需求增加的跡象,而高收入消費者的支出則保持韌性,」聯準會發布的褐皮書顯示。 農業部門的活動喜憂參半,農作物價格上漲抵消了化肥和燃油成本的飆升。 據美國農場局聯合會稱,由於霍爾木茲海峽實際關閉導致供應中斷,美國農民面臨化肥價格上漲的壓力。 聯準會發布的褐皮書顯示,儘管所有地區都報告稱,由於中東衝突,能源和燃油成本大幅上漲,但絕大多數地區的價格總體上漲幅溫和。美國勞工統計局週五公佈的數據顯示,3月美國消費者通膨率加速至近四年來的最高月度水準。 聯準會文件顯示,就業情況穩定或略有成長,僅有一個地區報告略有下降。文件也顯示,在勞動市場方面,由於人員流動率低、裁員人數極少,大多數地區的勞動力需求保持穩定。 聯準會褐皮書指出,“由於對未來形勢普遍存在不確定性,企業前景不一。” 上週公佈的聯準會3月17日至18日政策會議紀錄顯示,鑑於伊朗戰爭加劇了通膨和就業風險,聯準會應「靈活」調整貨幣政策。
Related Articles
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.